Tyra Biosciences, Inc. (TYRA) has a consensus analyst rating of Buy, based on 7 analysts covering the stock. Of those, 7 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for TYRA is $49.80, representing a +41.2% upside from the current price of $35.27. Price targets range from a low of $42.00 to a high of $59.00.
